BACKGROUND: Patient navigation is an intervention aimed at reducing barriers to health care for underserved populations as a means to reduce cancer health disparities. Despite the proliferation of patient navigation programs across the United States, information related to the economic impact and sustainability of these programs is lacking. METHODS: After a review of the relevant literature, the Health Services Research (HSR)-Cost workgroup of the American Cancer Society National Patient Navigator Leadership Summit met to examine cost data relevant to assessing the economic impact of patient navigation and to propose common cost metrics. RESULTS: Recognizing that resources available for data collection, management, and analysis vary, 5 categories of core and optional cost measures were identified related to patient navigator programs, including program costs, human capital costs, direct medical costs, direct non-medical costs, and indirect costs. CONCLUSIONS: Information demonstrating economic as well as clinical value is necessary to make decisions about sustainability of patient navigation programs. Adoption of these common cost metrics are recommended to promote understanding of the economic impact of patient navigation and comparability across diverse patient navigation programs.
BACKGROUND:Patient navigation is an intervention aimed at reducing barriers to health care for underserved populations as a means to reduce cancer health disparities. Despite the proliferation of patient navigation programs across the United States, information related to the economic impact and sustainability of these programs is lacking. METHODS: After a review of the relevant literature, the Health Services Research (HSR)-Cost workgroup of the American Cancer Society National Patient Navigator Leadership Summit met to examine cost data relevant to assessing the economic impact of patient navigation and to propose common cost metrics. RESULTS: Recognizing that resources available for data collection, management, and analysis vary, 5 categories of core and optional cost measures were identified related to patient navigator programs, including program costs, human capital costs, direct medical costs, direct non-medical costs, and indirect costs. CONCLUSIONS: Information demonstrating economic as well as clinical value is necessary to make decisions about sustainability of patient navigation programs. Adoption of these common cost metrics are recommended to promote understanding of the economic impact of patient navigation and comparability across diverse patient navigation programs.
Authors: Scott B Cantor; Lawrence B Levy; Marylou Cárdenas-Turanzas; Karen Basen-Engquist; Tao Le; J Robert Beck; Michele Follen Journal: Med Decis Making Date: 2006 May-Jun Impact factor: 2.583
Authors: Josephine A Mauskopf; Sean D Sullivan; Lieven Annemans; Jaime Caro; C Daniel Mullins; Mark Nuijten; Ewa Orlewska; John Watkins; Paul Trueman Journal: Value Health Date: 2007 Sep-Oct Impact factor: 5.725
Authors: Larissa Myaskovsky; Donna Almario Doebler; Donna M Posluszny; Mary Amanda Dew; Mark Unruh; Linda F Fried; Galen E Switzer; Sunghee Kim; Chung-Chou H Chang; Mohan Ramkumar; Ron Shapiro Journal: Transplantation Date: 2012-02-27 Impact factor: 4.939
Authors: Rachel S Ruderman; Emma C Dahl; Brittney R Williams; Joe M Feinglass; Michelle A Kominiarek; William A Grobman; Lynn M Yee Journal: Health Educ Behav Date: 2021-10-12
Authors: Mona N Fouad; Aras Acemgil; Sejong Bae; Andres Forero; Nedra Lisovicz; Michelle Y Martin; Gabriela R Oates; Edward E Partridge; Selwyn M Vickers Journal: J Oncol Pract Date: 2016-05-17 Impact factor: 3.840
Authors: Mark E Bensink; Scott D Ramsey; Tracy Battaglia; Kevin Fiscella; Thelma C Hurd; June M McKoy; Steven R Patierno; Peter C Raich; Eric E Seiber; Victoria Warren-Mears; Elizabeth Whitley; Electra D Paskett; S Mandelblatt Journal: Cancer Date: 2013-10-25 Impact factor: 6.860
Authors: Rahel G Ghebre; Lovell A Jones; Jennifer A Wenzel; Michelle Y Martin; Raegan W Durant; Jean G Ford Journal: Cancer Date: 2014-04-01 Impact factor: 6.860
Authors: Ashley A White; Aissatou Ba; Trevor Daniel Faith; Viswanathan Ramakrishnan; Clara L Dismuke-Greer; Jim C Oates; Edith Marie Williams Journal: Lupus Sci Med Date: 2021-05
Authors: C Allary; A Bourmaud; F Tinquaut; M Oriol; J Kalecinski; V Dutertre; N Lechopier; M Pommier; Y Benoist; S Rousseau; V Regnier; V Buthion; F Chauvin Journal: BMC Cancer Date: 2016-07-07 Impact factor: 4.430